ProQR Therapeutics
PRQR
PRQR
62 hedge funds and large institutions have $82.4M invested in ProQR Therapeutics in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 16 increasing their positions, 21 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
3% less funds holding
Funds holding: 64 → 62 (-2)
24% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 21
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Holders
62
Holding in Top 10
2
Calls
$150K
Puts
$20K
Top Buyers
| 1 | +$3.47M | |
| 2 | +$1.77M | |
| 3 | +$439K | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$364K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$229K |
Top Sellers
| 1 | -$3.06M | |
| 2 | -$1.56M | |
| 3 | -$1.31M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$897K |
| 5 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
-$205K |
